Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)

NCT05497843 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Chiauranib

Sponsor

Chipscreen Biosciences, Ltd.